BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 9869520)

  • 21. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
    Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
    J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.
    Worni M; Akushevich I; Greenup R; Sarma D; Ryser MD; Myers ER; Hwang ES
    J Natl Cancer Inst; 2015 Dec; 107(12):djv263. PubMed ID: 26424776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
    Wapnir IL; Dignam JJ; Fisher B; Mamounas EP; Anderson SJ; Julian TB; Land SR; Margolese RG; Swain SM; Costantino JP; Wolmark N
    J Natl Cancer Inst; 2011 Mar; 103(6):478-88. PubMed ID: 21398619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ductal carcinoma-in-situ: long-term results of breast-conserving therapy.
    Mirza NQ; Vlastos G; Meric F; Sahin AA; Singletary SE; Newman LA; Kuerer HM; Ames FC; Ross MI; Feig BW; Pollock RE; Buchholz TA; McNeese MD; Strom EA; Hortobagyi GN; Hunt KK
    Ann Surg Oncol; 2000 Oct; 7(9):656-64. PubMed ID: 11034242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of subsequent invasive breast cancer after a diagnosis of ductal carcinoma in situ (DCIS).
    Cheung S; Booth ME; Kearins O; Dodwell D
    Breast; 2014 Dec; 23(6):807-11. PubMed ID: 25270228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ductal carcinoma in situ (DCIS) treated by mastectomy, or local excision with or without radiotherapy: A monocentric, retrospective study of 608 women.
    Frank S; Dupont A; Teixeira L; Porcher R; De Roquancourt A; Giacchetti S; Espié M; Cuvier C
    Breast; 2016 Feb; 25():51-6. PubMed ID: 26573444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of breast recurrence in a pilot study of brachytherapy confined to the lumpectomy site for early breast cancer with six years' minimum follow-up.
    Perera F; Yu E; Engel J; Holliday R; Scott L; Chisela F; Venkatesan V
    Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1239-46. PubMed ID: 14630257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in the treatment of ductal carcinoma in situ of the breast.
    Baxter NN; Virnig BA; Durham SB; Tuttle TM
    J Natl Cancer Inst; 2004 Mar; 96(6):443-8. PubMed ID: 15026469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situ.
    Arvold ND; Punglia RS; Hughes ME; Jiang W; Edge SB; Javid SH; Laronga C; Niland JC; Theriault RL; Weeks JC; Wong YN; Lee SJ; Hassett MJ
    Cancer; 2012 Dec; 118(24):6022-30. PubMed ID: 22674478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current Therapeutic Approaches to DCIS.
    Doke K; Butler S; Mitchell MP
    J Mammary Gland Biol Neoplasia; 2018 Dec; 23(4):279-291. PubMed ID: 30267199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy.
    Rakovitch E; Nofech-Mozes S; Hanna W; Sutradhar R; Gu S; Fong C; Tuck A; Youngson B; Miller N; Done SJ; Chang MC; Sengupta S; Elavathil L; Jani PA; Bonin M; Lalani N; Paszat L
    Breast; 2018 Feb; 37():181-186. PubMed ID: 28781102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Five year outcome of 145 patients with ductal carcinoma in situ (DCIS) after accelerated breast radiotherapy.
    Ciervide R; Dhage S; Guth A; Shapiro RL; Axelrod DM; Roses DF; Formenti SC
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e159-64. PubMed ID: 22579378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized Phase III Trial Evaluating Radiation Following Surgical Excision for Good-Risk Ductal Carcinoma In Situ: Long-Term Report From NRG Oncology/RTOG 9804.
    McCormick B; Winter KA; Woodward W; Kuerer HM; Sneige N; Rakovitch E; Smith BL; Germain I; Hartford AC; O'Rourke MA; Walker EM; Strom EA; Hopkins JO; Pierce LJ; Pu AT; Sumida KNM; Vesprini D; Moughan J; White JR
    J Clin Oncol; 2021 Nov; 39(32):3574-3582. PubMed ID: 34406870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncoplastic breast surgery for the management of ductal carcinoma in situ (DCIS): is it oncologically safe? A retrospective cohort analysis.
    De Lorenzi F; Di Bella J; Maisonneuve P; Rotmensz N; Corso G; Orecchia R; Colleoni M; Mazzarol G; Rietjens M; Loschi P; Marcelli S; Veronesi P; Galimberti V
    Eur J Surg Oncol; 2018 Jul; 44(7):957-962. PubMed ID: 29759643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge.
    Cabioglu N; Krishnamurthy S; Kuerer HM; Hunt KK; Singletary SE; Meric-Bernstam F; Ross MI; Feig BW; Ames FC; Babiera GV
    Cancer; 2004 Aug; 101(3):508-17. PubMed ID: 15274063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nipple-sparing mastectomy as treatment for patients with ductal carcinoma in situ: A 10-year follow-up study.
    Lago V; Maisto V; Gimenez-Climent J; Vila J; Vazquez C; Estevan R
    Breast J; 2018 May; 24(3):298-303. PubMed ID: 29139613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytologic evaluation of lumpectomy margins in patients with ductal carcinoma in situ: clinical outcome.
    Cox CE; Hyacinthe M; Gonzalez RJ; Lyman G; Reintgen D; Ku NN; Miller MS; Greenberg H; Nicosia SV
    Ann Surg Oncol; 1997 Dec; 4(8):644-9. PubMed ID: 9416412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ductal carcinoma in situ on core needle biopsy only with no residual disease at surgery.
    Dubrovsky E; Nguyen P; Chun J; Schwartz S; Raymond S; Guth A; Schnabel F; Gerber NK
    Breast J; 2018 Nov; 24(6):971-975. PubMed ID: 30062749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multidisciplinary Shared Decision Making in the Management of Ductal Carcinoma In Situ of the Breast.
    Parikh P; Pockaj B; Wasif N; Halyard M; Wong W; Kosiorek HE; Dueck AC; Gray R
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3(0 3):S516-21. PubMed ID: 25986869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.